Delivery Order SPE2DR25D1109-SPE2DR26FFH7E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,644.43 to AmerisourceBergen Drug Corp for Belbuca 300 mcg film (60 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which is not set aside, represents a pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,743.95 delivery order for Belbuca 600 microgram film (60 units) on December 4, 2025, with a completion date of December 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a transactional procurement under AmerisourceBergen's broader relationship with the federal government's medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,774.31 to AmerisourceBergen Drug Corp for 60 units of Belbuca 900 micrograms film on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Belbuca is a buccal film formulation used for opioid pain management in opioid-tolerant patients,...
- The Defense Logistics Agency awarded a $1,301.28 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for Belbuca 450 mcg film, with an ultimate completion date of September 19, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. Belbuca is a buccal film formulation used for pain management in opioid-tolerant patients. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,045.41 to AmerisourceBergen Drug Corp for 60 units of Belbuca 600 microgram film on November 5, 2025, with completion scheduled for November 6, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,093.70 to AmerisourceBergen Drug Corp for the supply of Belbuca 750 microgram film (60 count) on December 3, 2025, with completion scheduled for December 4, 2025. This non-competitive delivery order represents a firm fixed price transaction utilizing a competitively awarded indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,027.72 to AmerisourceBergen Drug Corp for BELBUCA 150 MCG film (60 units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitive award utilized firm fixed pricing and required no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Belbuca 600 mcg film (60 count) with a ceiling value of $1,123.96. This firm fixed price delivery order represents a non-competitive, non-set-aside award and is set for ultimate completion by October 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Belbuca 600 microgram films (60 count). This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,683.50 with firm fixed pricing and an ultimate completion date of October 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,455.48 delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 microgram film (60 count) on September 19, 2025, with completion targeted for September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFH7EDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,038.74 to AmerisourceBergen Drug Corp for Belbuca 450 MCG film in a quantity of 60 units. This order, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a firm fixed-price procurement with no set-aside designation. The award was made competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Belbuca is a transmucosal buccal film formulation used for opioid pain management in opioid-tolerant patients. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications and medical supplies to military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order exemplifies the company's role in fulfilling routine pharmaceutical procurement requirements across the Department of Defense healthcare enterprise, supporting military medical readiness and patient care needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/9/25 |